Ionis Pharmaceuticals, Inc. (IONS) Financials
IONS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 3.0 billion | 2.6 billion |
| 2023-09-30 | 2.9 billion | 2.6 billion |
| 2023-06-30 | 3.0 billion | 2.5 billion |
| 2023-03-31 | 2.9 billion | 2.4 billion |
IONS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 33.7 million | 26.3 million |
| 2023-09-30 | -112.3 million | 26.0 million |
| 2023-06-30 | -110.4 million | 26.6 million |
| 2023-03-31 | -145.7 million | 26.9 million |
IONS Net Income
No data available :(
IONS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 2.3 billion | - | 170.9 million |
| 2023-09-30 | 2.2 billion | - | 173.0 million |
| 2023-06-30 | 2.4 billion | 1.3 billion | 175.0 million |
| 2023-03-31 | 2.3 billion | 1.2 billion | 177.0 million |
IONS Shares Outstanding
IONS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 819000 | 256.6 million | 71.0 million | - |
| 2023-09-30 | 3.2 million | 215.0 million | 70.0 million | - |
| 2023-06-30 | 13.1 million | 230.0 million | 46.1 million | 100000 |
| 2023-03-31 | 11.7 million | 198.0 million | 45.5 million | 484000 |
IONS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 324.5 million | 3.1 million |
| 2023-09-30 | 144.0 million | 2.0 million |
| 2023-06-30 | 188.0 million | 3.0 million |
| 2023-03-31 | 131.0 million | 1.0 million |
IONS
Price: $41.97
52 week price:
Earnings Per Share: -2.51 USD
P/E Ratio: -17.41
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.1 million
Ebitda: 9.5 millionMarket Capitalization: 6.2 billion